Products & Services

Diagnostic Products

Technetium-99m Labeled Products
^99mTc-bicisate (Neurolite®)
^99mTc-exametazime (Ceretec®)
^99mTc-microaggregated Albumin (MAA)
^99mTc-mebrofenin
^99mTc-medronate (MDP)
^99mTc-mertiatide (Technescan® MAG-3®)
^99mTc-pentetate (DTPA)
^99mTc-sodium pertechnetate
^99mTc-pyrophosphate (Technescan®PYP®)
^99mTc-sestamibi
^99mTc-succimer (DMSA)
^99mTc-sulfur colloid
^99mTc-tetrofosmin (Myoview®)
^99mTc-technetium in vitro erythrocyte labeling (Ultratag®)

Indium-111 Labeled Diagnostic Products
¹¹¹In-pentetate (¹¹¹In-DTPA)
¹¹¹In-oxyquinoline (indium oxine)
¹¹¹In-capromab pendetide (ProstaScint®)
¹¹¹In-pentreotide (Octreoscan®)

Iodine Labeled Diagnostic Products
¹²³I-sodium iodide capsules
¹²³I-iobenguane (mIBG)
¹²⁵I-iodohydroxybenzenesulfonate (HBS)
¹²⁵I-human serum albumin (HSA)
¹³¹I-iobenguane (mIGB)
¹³¹I-sodium iodide capsules

Other Diagnostic Products
¹⁴C-urea
⁵¹Cr-sodium chromate
⁶⁷Ga-gallium citrate
³²P-chromic phosphate
³²P-sodium phosphate
⁸²Ru-rubidium chloride (Cardiogen®)
²⁰¹Tl-thallous chloride
¹³³Xe-xenon

Therapeutic Products

¹³¹I-sodium iodide capsules (custom compounded)
¹³¹I-tositumomab (Bexxar®)
¹⁵³Sm-samarium lexidronam (Quadramet®)
⁸⁹Sr-strontium chloride (Metastron®)
⁹⁰Y/¹¹¹In –ibritumomab tiuxetan (Zevalin®)

Interventional Agents

Acetazolamide
Adenosine (Adenoscan®)
Aminophylline
Anticoagulant citrate dextrose solution (ACD)
Ascorbic acid
Atropine
Bethanechol
Captopril
Cimetadine
Dipyridamole
Dobutamine
Enalaprilat
Famotidine
Furosemide
Glucagon
Heparin
Hetastarch
Metoclopramide
Potassium iodide
Potassium perchlorate
Ranitidine
Regadenoson (Lexiscan®)
Sincalide (Kinevac®; CCK)
Thyroid-stimulating hormone (thyrotropin; TSH)

Lab Equipment & Radioactive Sources

Aerosol systems and accessories
Ba-133 Source
Co-57 source
Cs-137 source
Lead products
Syringes
Syringe shields
Sharps containers
Vial shields

Services

Clinical research consulting in nuclear medicine
In vitro blood labeling
Lab equipment procurement
Licensing
Radiation department audits
Radiation safety program implementation and monitoring
Radioactive source disposal
Radiopharmacy consultation and drug information

*Product availability to the end user is contingent on availability from the manufacturer(s).